Should we target allergen protease activity to decrease the burden of allergic airway inflammation? | Inflamm Allergy Drug Targets;7(4): 288-95, 2008 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Should we target allergen protease activity to decrease the burden of allergic airway inflammation?

Vliagoftis, Harissios; Forsythe, Paul.

Affiliation

Vliagoftis H; Pulmonary Research Group, University of Alberta, Edmonton, Alberta, Canada. harissios.vliagoftis@ualberta.ca

Inflamm Allergy Drug Targets ; 7(4): 288-95, 2008 Dec.

Article in En | MEDLINE | ID: mdl-19075793

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Hydrolases / Protease Inhibitors / Respiratory Hypersensitivity / Allergens Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Inflamm Allergy Drug Targets Journal subject: ALERGIA E IMUNOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Hydrolases / Protease Inhibitors / Respiratory Hypersensitivity / Allergens Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Inflamm Allergy Drug Targets Journal subject: ALERGIA E IMUNOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country: